Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Gastrimmune enters phase III trials for pancreatic cancer

Nov. 20, 1998

Parke-Davis identifies potent inhibitor of PDGF receptor TK and PDGF-dependent tumor growth

Nov. 20, 1998

Antitumor tetramic acid compound produced by Streptomyces

Nov. 20, 1998

Clarion prepares novel compounds for cancer, psoriasis and inflammation

Nov. 20, 1998

Vertex reports preliminary data on Incel in soft tissue carcinoma and initiates new phase II trial

Nov. 20, 1998

MPIF advances to phase II trials in cancer patients

Nov. 19, 1998

First potent, orally active LHRH antagonist discovered by Takeda

Nov. 19, 1998

U.S. patent protects methods of angiogenesis inhibition using Xoma's BPI products

Nov. 19, 1998

FDA advisory committee issues positive statement on DepoCyt

Nov. 18, 1998

Novel MMP inhibitor synthesized at Abbott shows potent antitumor activity in vivo

Nov. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...